Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

In its most basic form, dopamine décor looks like a use of bold colours, playful patterns, nostalgic objects, and lots of ...

Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and ...

We're all familiar with Pavlovian conditioning, in which a reward-anticipatory behavior follows a reward-predicting stimulus. Perhaps you experience it yourself when passing a cafe or restaurant and ...

Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

New research expands on current understanding of the brain chemical dopamine, finding that it plays a role in reducing the value of memories associated with rewards. The study opens new avenues for ...

Emalex Biosciences’ dopamine blocker led to fewer patients ... The phase 3 study enrolled 167 children and 49 adults, according to a Feb. 25 press release. After a 12-week open-label period ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for a ...